Outcomes’10 | Market & Patient Access is part of ProductLife Group, a global end to end consulting partner supporting Life Sciences companies across the entire product lifecycle.

From Spain, we provide specialised expertise in Health Economics, Outcomes Research (HEOR), Market Access, and Patient Access, supporting Pharmaceutical, Biotech, and MedTech companies in generating robust evidence, demonstrating value, and enabling informed pricing, reimbursement, and access decisions in complex, highly regulated healthcare environments.

Grounded in scientific rigour and strategic clarity, we integrate clinical, economic, and patient perspectives to translate complex data into clear, decision ready value narratives that support HTA processes, payer engagement, and sustainable access to innovation.

Working in close collaboration with ProductLife Group’s regulatory, medical, safety, and lifecycle teams, Outcomes’10 contributes to a globally integrated, one stop shop offering, ensuring alignment across development, launch and lifecycle management.

Our areas of expertise include:
•	Evidence generation across clinical, economic, and patient centred outcomes
•	Real world evidence (RWE), observational research, preference and outcomes studies
•	Health economic evaluations and value communication, including modelling, value dossiers, and HTA oriented materials
•	Patient centred approaches, including PRO development, outcomes measurement, and patient support initiatives
•	Strategic stakeholder engagement and scientific communication, including publications, medical writing, advisory activities, and capability building
•	End to end project support, from study design to results dissemination and access focused deliverables

By enabling evidence based, sustainable access decisions, Outcomes’10 supports ProductLife Group’s mission to improve human health and deliver long term value across healthcare systems.

Outcomes'10

Org chart

Teams

Offices